Tresivac PFS MMR Vaccine

Description

TRESIVAC PFS is a high-efficacy, live attenuated combination vaccine containing Measles, Mumps, and Rubella (MMR) viruses. Manufactured by the Serum Institute of India, the world’s largest vaccine producer, it is designed for the active immunization of children and susceptible adults. The “PFS” designation stands for Pre-Filled Syringe, which ensures precise dosing, minimizes the risk of contamination, and simplifies administration. Tresivac works by introducing weakened forms of the viruses into the body, stimulating the immune system to produce long-lasting antibodies. This “Triple Shield” protection is a cornerstone of global pediatric healthcare, preventing serious complications such as deafness, encephalitis, and congenital rubella syndrome.